Why the study?
Does continuous renal replacement therapy cause thrombocytopenia in critically ill patients?
Does continuous renal replacement therapy cause thrombocytopenia in critically ill patients?
CRRT is associated with a transient, reversible drop in platelets averaging 48% within the first 5 days of therapy in critically ill patients.
No takes yet. Share an insight, caveat, or question.
May warrant platelet monitoring early in CRRT; leaves open causality and effects on bleeding or outcomes.
Ferreira et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: